Provision of Clinical Trial Monitoring to the FaR-RMS Trial
Tender for the Provision of Clinical Trial Monitoring to the FaR-RMS Trial · Closed
- Buyer
- Tender for the Provision of Clinical Trial Monitoring to the FaR-RMS Trial
- Status
- Closed
- Country
- United Kingdom
- Region
- England
- Sector
- Professional Services
- Reference
- FaT-ocds-h6vhtk-02a184
- Published
- 2021-03-31
- Deadline
- 2021-04-30
Tender summary
The FaR-RMS trial The University of Birmingham Cancer Research Clinical Trials Unit are working on a collaboration with a large Pharmaceutical company to add a new arm to an existing study. The trial is a multicentre, randomised phase II trial evaluating the new therapy against a control arm in paediatric patients with relapsed/refractory rhabdomyosarcoma. Patients will receive therapy for up to 12 cycles (approx. 12 months) and will be followed-up for 5 years.
This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.
Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.
Register for full access